Nicholas Lorusso
Stock Analyst at TD Cowen
(3.67)
# 2,140
Out of 5,125 analysts
19
Total ratings
50%
Success rate
25.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $10 → $16 | $8.08 | +98.02% | 2 | Sep 29, 2026 | |
| KROS Keros Therapeutics | Rated: Hold | n/a | $9.33 | - | 4 | Aug 21, 2026 | |
| IMTX Immatics | Reiterated: Buy | n/a | $6.42 | - | 5 | Aug 18, 2026 | |
| ARVN Arvinas | Reiterated: Hold | n/a | $6.92 | - | 1 | Aug 4, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Rated: Buy | $65 → $95 | $95.02 | -0.02% | 7 | Jul 28, 2026 |
Iovance Biotherapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $10 → $16
Current: $8.08
Upside: +98.02%
Keros Therapeutics
Aug 21, 2026
Rated: Hold
Price Target: n/a
Current: $9.33
Upside: -
Immatics
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.42
Upside: -
Arvinas
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.92
Upside: -
Kiniksa Pharmaceuticals International,
Jul 28, 2026
Rated: Buy
Price Target: $65 → $95
Current: $95.02
Upside: -0.02%